INBS
INBS
NASDAQ · Health Care

Intelligent Bio Solutions In

$1.65
-0.05 (-2.94%)
As of Sep 28, 10:43 PM ET ·
Financial Highlights (FY 2026)
Revenue
9.17M
Net Income
-27,052,448
Gross Margin
48.6%
Profit Margin
-294.9%
Rev Growth
+49.7%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 48.6% 48.6% 43.3% 43.3%
Operating Margin -299.1% -269.2% 14.6% 14.1%
Profit Margin -294.9% -280.2% 12.3% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.17M 6.13M 2.43M 2.55M
Gross Profit 4.46M 2.98M 1.05M 1.11M
Operating Income -27,437,456 -16,497,668 355.4K 360.4K
Net Income -27,052,448 -16,266,169 299.8K 314.6K
Gross Margin 48.6% 48.6% 43.3% 43.3%
Operating Margin -299.1% -269.2% 14.6% 14.1%
Profit Margin -294.9% -280.2% 12.3% 12.3%
Rev Growth +49.7% +49.7% +12.5% -7.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 3.58M 2.96M
Total Equity — — 5.90M 5.31M
D/E Ratio — — 0.61 0.56
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,905,097 -15,806,949 505.3K 509.1K
Free Cash Flow — — 188.2K 257.9K